 |
|
The Role and Value of Pharmaceutical Marketing
Richard Levy, PhD
Arch Fam Med. 1994;3(4):327-332.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
1. The Boston Consulting Group. The Changing Environment for U.S. Pharmaceuticals: The Role of Pharmaceutical Companies in a Systems Approach to Health Care. New York, NY: The Boston Consulting Group; 1993:70.
2. Hearings Before the Committee on Labor and Human Resources, US Senate (December 11-12, 1990) (testimony of D. G. Watson). 3. Kessler D. Drug promotions and scientific exchange. N Engl J Med. 1991;325:201-203.
PUBMED
4. Drug Marketing, Advertising and Communications Selected Calendar 1992 Information and Accomplishment Data of the Center for Drug Evaluation and Research. Washington, DC: US Dept of Health and Human Services; 1993. 5. Dougherty MJ. Assuring the value of marketing. Presented at the Pharmaceutical Manufacturers Association Annual Marketing Section Meeting; April 4-7, 1993; Tucson, Ariz. 6. Pharmaceutical Manufacturers Association. Promotion Practices in the Pharmaceutical Industry. Washington, DC: Pharmaceutical Manufacturers Association; 1991. 7. Kolassa M. Reductions in Pharmaceutical Price Growth: An Assessment of the List Price Changes in the U.S. Pharmaceutical Market 1989 to 1992. Oxford: Research Institute of the Pharmaceutical Sciences, University of Mississippi; 1993. 8. Beckwith C, Munger MA. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction. Ann Pharmacother. 1993;27:755-766.
ABSTRACT
9. McAllister JC, deLeon RF, Guerci AD, Ross AM. t-PA: cost effectiveness and formulary considerations. Clin Courier. 1989;7:1-8.
10. Greenberg PE, Stiglen LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990. J Clin Psychiatry. 1993:54:405-418.
PUBMED
|
